Title : Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19.

Pub. Date : 2022 Apr 10

PMID : 35397768






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 To develop a population pharmacokinetic model for midazolam in adult intensive care unit patients infected with COVID-19 and to assess the effect of inflammation, reflected by IL-6, on the pharmacokinetics of midazolam. Midazolam interleukin 6 Homo sapiens
2 Midazolam clearance was reduced by increased IL-6 and IL-6 explained more of the variability within our patients than CRP. Midazolam interleukin 6 Homo sapiens
3 Midazolam clearance was reduced by increased IL-6 and IL-6 explained more of the variability within our patients than CRP. Midazolam interleukin 6 Homo sapiens
4 The midazolam clearance was reduced by 24% (6.7-5.1 L/h) when IL-6 increases from population median 116 to 300 pg/mL. Midazolam interleukin 6 Homo sapiens
5 CONCLUSIONS: Inflammation, reflected by high IL-6, reduces midazolam clearance in critically ill patients with COVID-19. Midazolam interleukin 6 Homo sapiens